Cargando…
Paget’s Disease and Secondary Hyperparathyroidism: Is Healing Possible?
Paget bone disease (PDB) is often asymptomatic and incidentally diagnosed. It is a cause of osteoporosis and bone fragility and exposes patients to a high incidence of bone fractures. In Europe the prevalence varies according to the geographical area of origin, and increases with age. In patients wi...
Autores principales: | Panuccio, Vincenzo Antonio, Tripepi, Rocco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273920/ https://www.ncbi.nlm.nih.gov/pubmed/32548119 http://dx.doi.org/10.3389/fcell.2020.00399 |
Ejemplares similares
-
Update on the pathogenesis and genetics of Paget’s disease of bone
por: Gennari, Luigi, et al.
Publicado: (2022) -
Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”
por: Russo, Domenico, et al.
Publicado: (2019) -
Epigenetic DNA Methylation Signatures Associated With the Severity of Paget’s Disease of Bone
por: Diboun, Ilhame, et al.
Publicado: (2022) -
Correction: Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”. J. Clin. Med. 2019, 8, 1066
por: Russo, Domenico, et al.
Publicado: (2020) -
Does Etelcalcetide reverse myelofibrotic bone changes due to hyperparathyroidism? A case report
por: Panuccio, Vincenzo Antonio, et al.
Publicado: (2023)